Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang He

Showing results (151-160 of 1,978) with videos related to

Pageof 198
Sort By:
Asian Journal of Surgery|February 13, 2021
Hepatic metastasis of the ovarian granulosa cell tumor after 11 years of surgical resection and systemic chemotherapy of primary tumors: A case reportYang He, Yi Yang, Tao Wang, et al.
Anti-Cancer Drugs|August 10, 2022
Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature reviewHao Wang, Yang He, Weipeng Zhao, et al.
Journal of Ovarian Research|February 22, 2025
TAM-derived exosomal miR-589-3p accelerates ovarian cancer progression through BCL2L13Jianqing Wang, Yan Zhu, Yang He, et al.
RSC Advances|February 10, 2025
Nanoscale drug formulations for the treatment of Alzheimer's disease progressionLiqin Liu, Haini He, Bin Du, et al.
Investigational New Drugs|June 3, 2024
Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitisPanpan Luo, Yuge Guo, Yang He, et al.
Discover Oncology|June 4, 2024
Role of lipid metabolism in hepatocellular carcinomaYulin Cheng, Jun He, Bin Zuo, et al.
Drug Development Research|April 15, 2024
YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistanceJian Yang, Yawen Chen, Yang He, et al.
Current Eye Research|March 7, 2024
BMSC Alleviates Dry Eye by Inhibiting the ROS-NLRP3-IL-1β Signaling Axis by Reducing Inflammation LevelsDandan Zhao, Hongxia Zhao, Yang He, et al.
Biomacromolecules|June 13, 2023
Topology Effects of Poly(2-ethyl-2-oxazoline) Brushes with Various Architectures for Antifouling Behavior under Shear FlowSonglin Xing, Qiqi Wang, Yang He, et al.
Hepatology International|March 30, 2026
Re-examining the incremental benefit of TACE-TKI-PD-1 triplet therapy: time-related bias and treatment pathways in a real-world HCC cohortYuanqin Zhang, Yang He, Yifei Chen, et al.
Pageof 198

Showing results (151-160 of 1,978) with videos related to

Sort By:
Pageof 198
Asian Journal of Surgery|February 13, 2021
Hepatic metastasis of the ovarian granulosa cell tumor after 11 years of surgical resection and systemic chemotherapy of primary tumors: A case reportYang He, Yi Yang, Tao Wang, et al.
Anti-Cancer Drugs|August 10, 2022
Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature reviewHao Wang, Yang He, Weipeng Zhao, et al.
Journal of Ovarian Research|February 22, 2025
TAM-derived exosomal miR-589-3p accelerates ovarian cancer progression through BCL2L13Jianqing Wang, Yan Zhu, Yang He, et al.
RSC Advances|February 10, 2025
Nanoscale drug formulations for the treatment of Alzheimer's disease progressionLiqin Liu, Haini He, Bin Du, et al.
Investigational New Drugs|June 3, 2024
Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitisPanpan Luo, Yuge Guo, Yang He, et al.
Discover Oncology|June 4, 2024
Role of lipid metabolism in hepatocellular carcinomaYulin Cheng, Jun He, Bin Zuo, et al.
Drug Development Research|April 15, 2024
YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistanceJian Yang, Yawen Chen, Yang He, et al.
Current Eye Research|March 7, 2024
BMSC Alleviates Dry Eye by Inhibiting the ROS-NLRP3-IL-1β Signaling Axis by Reducing Inflammation LevelsDandan Zhao, Hongxia Zhao, Yang He, et al.
Biomacromolecules|June 13, 2023
Topology Effects of Poly(2-ethyl-2-oxazoline) Brushes with Various Architectures for Antifouling Behavior under Shear FlowSonglin Xing, Qiqi Wang, Yang He, et al.
Hepatology International|March 30, 2026
Re-examining the incremental benefit of TACE-TKI-PD-1 triplet therapy: time-related bias and treatment pathways in a real-world HCC cohortYuanqin Zhang, Yang He, Yifei Chen, et al.
Pageof 198